Skip to search formSkip to main contentSkip to account menu

NS398

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE To investigate the beneficial effects of Anaxagorea luzonensis (AL) extract on homocysteine thiolactone (HTL)-induced… 
2008
2008
Bone remodelling occurs in humans throughout life, therefore bone is continuously renewed to better respond to changes in… 
2008
2008
Objective To investigate the mechanism of the effects that cyclooxygenase inhibitor, NS398 exerts on the endometrial carcinoma… 
2007
2007
Cyclooxygenase 2 (COX-2) pathway inhibitors were regarded as promising nonsteroidal antiinflammatory drugs (NSAIDs). We… 
2006
2006
Chemotherapy to date has not been effective in the treatment of human hepatocellular carcinoma. More effective treatment… 
2005
2005
【Objective】To reaserch if COX-2 selective inhibitor, NS398, could prevent mice's skin photoaging. 【Methods】8-MOP and UVA were… 
2001
2001
Bae et al. [(1)][1] report in this issue of Clinical Cancer Research that COX-2[3][2] is expressed in a subset of human… 
2001
2001
Nitric oxide (NO) is a free radical, is known to play an important role in many physiological and pathological processes… 
2000
2000
Tumor-secreted products can affect macrophage cytokine expression and in that way alter the immune response. Prostaglandins (PGs… 
2000
2000
Cyclooxygenase-2 (Cox-2), an enzyme responsible for catalyzing the committed step in prostanoid biosynthesis, is the product of…